David Luci
Founder chez ACURX PHARMACEUTICALS, INC.
Fortune : 3 M $ au 31/03/2024
Profil
David P.
Luci was the founder of Dipexium Pharmaceuticals, Inc. (founded in 2010) and Acurx Pharmaceuticals, Inc. (founded in 2017), where he held the titles of President, CEO, Secretary & Director and President, Chief Executive Officer & Director, respectively.
He currently holds the position of Chairman at Digital Prime Technologies and is a Member of the New York State Bar Association.
Mr. Luci's former positions include President & Director at MacroChem Corp.
(2007-2009), Director at Abeona Therapeutics, Inc. (2009-2010), Director at Ameri Holdings, Inc. (2018-2019), and CFO, Secretary, Executive VP & General Counsel at Bioenvision, Inc. (2002-2007).
He was also a Corporate Associate at Paul, Hastings, Janofsky & Walker LLP (1994-2002) and a Senior Auditor at Ernst & Young LLP.
Mr. Luci received his undergraduate degree from Bucknell University and his graduate degree from Albany Law School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/04/2024 | 1 098 280 ( 7,59% ) | 3 M $ | 31/03/2024 |
Postes actifs de David Luci
| Sociétés | Poste | Début |
|---|---|---|
| ACURX PHARMACEUTICALS, INC. | Founder | 01/07/2017 |
New York State Bar Association
 New York State Bar Association Miscellaneous Commercial ServicesCommercial Services New York State Bar Association is a non-profit organization, which provides legal services and offers a membership program for lawyers. It also publishes an array of books, bar journals, law digest, and State Bar news. The company was founded in 1876 and is headquartered in Alban, NY. | Corporate Officer/Principal | - |
Digital Prime Technologies
 Digital Prime Technologies Information Technology ServicesTechnology Services Digital Prime Technologies provides prime brokerage solutions for clients to enter the digital asset space with a fully customizable suite of services. The company is based in Jersey City, NJ. Digital Prime Technologies is built on traditional finance principles and industry practices that are core to US regulated securities markets. The company's product suite allows traditional Wall Street firms and other clients to customize their prime offering for digital assets, including custody providers, risk management, margin requirements, and liquidity partners. The company's offering enables broker-dealers and capital markets firms to transact in the digital asset space with robust and fully customizable services suited to their business and compliance needs. The company was founded in 2019 by James A Runnels, who has been the CEO since 2019. | Chairman | 01/03/2019 |
Anciens postes connus de David Luci
| Sociétés | Poste | Fin |
|---|---|---|
| ENVERIC BIOSCIENCES, INC. | Chairman | 12/12/2018 |
| PLX PHARMA WINDDOWN CORP. | Director/Board Member | 26/10/2017 |
Dipexium Pharmaceuticals, Inc.
 Dipexium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dipexium Pharmaceuticals, Inc. is a late stage pharmaceutical company, which is focused on the development and commercialization of Locilex, a potent and broad spectrum topical antibiotic peptide for the treatment of mild and moderate skin and skin structure infections. The company was founded by Robert J. DeLuccia and David P. Luci on January 14, 2010 and is headquartered in New York, NY. | Founder | 01/04/2017 |
| ABEONA THERAPEUTICS INC. | Director/Board Member | 01/01/2010 |
MacroChem Corp.
 MacroChem Corp. Pharmaceuticals: MajorHealth Technology MacroChem Corp. Develops pharmaceutical products to prevent chemicals in insect repellant from penetrating the skin. Its drug delivery technologies include Soft Enhancement of Percutaneous Absorption, MacroDem and DermaPass. The company was founded in 1982 and is located in Wellesley Hills, MI. | President | 01/02/2009 |
Formation de David Luci
| Bucknell University | Undergraduate Degree |
| Albany Law School | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ABEONA THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 10 |
|---|---|
MacroChem Corp.
MacroChem Corp. Pharmaceuticals: MajorHealth Technology MacroChem Corp. Develops pharmaceutical products to prevent chemicals in insect repellant from penetrating the skin. Its drug delivery technologies include Soft Enhancement of Percutaneous Absorption, MacroDem and DermaPass. The company was founded in 1982 and is located in Wellesley Hills, MI. | Health Technology |
Paul, Hastings, Janofsky & Walker LLP
 Paul, Hastings, Janofsky & Walker LLP Miscellaneous Commercial ServicesCommercial Services Paul, Hastings, Janofsky & Walker LLP provides legal solutions to financial institutions. Founded in Los Angeles, California in 1951, the firm operates in Asia, Europe, and the United States. | Commercial Services |
Bioenvision, Inc.
 Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Health Services |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Dipexium Pharmaceuticals, Inc.
Dipexium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dipexium Pharmaceuticals, Inc. is a late stage pharmaceutical company, which is focused on the development and commercialization of Locilex, a potent and broad spectrum topical antibiotic peptide for the treatment of mild and moderate skin and skin structure infections. The company was founded by Robert J. DeLuccia and David P. Luci on January 14, 2010 and is headquartered in New York, NY. | Health Technology |
New York State Bar Association
New York State Bar Association Miscellaneous Commercial ServicesCommercial Services New York State Bar Association is a non-profit organization, which provides legal services and offers a membership program for lawyers. It also publishes an array of books, bar journals, law digest, and State Bar news. The company was founded in 1876 and is headquartered in Alban, NY. | Commercial Services |
PLx Pharma, Inc.
 PLx Pharma, Inc. Pharmaceuticals: MajorHealth Technology PLx Pharma, Inc. is a late-stage specialty pharmaceutical company, which engages in the development and commercialization of a technology platform for approved drugs. It offers the PLxGuard delivery system, which uses surface acting lipids, such as phospholipids and free fatty acids, to modify the physiochemical properties of various drugs with a targeted release to select portions of the gastrointestinal (GI) tract. The company was founded by Ronald R. Zimmerman on November 12, 2002 and is headquartered in Dover, DE. | Health Technology |
Ameri Holdings, Inc.
 Ameri Holdings, Inc. Data Processing ServicesTechnology Services Ameri Holdings, Inc. is a technology services company, which specializes in systems, applications, and products (SAP) cloud, digital, and enterprise services. It offers technology consulting; business intelligence; cloud services; application development, integration, and maintenance; implementation services; infrastructure services; and independent validation services. The company was founded by Srinidhi Devanur in February 1994 and is headquartered in Suwanee, GA. | Technology Services |
| Acurx Pharmaceuticals, Inc. | |
Digital Prime Technologies
Digital Prime Technologies Information Technology ServicesTechnology Services Digital Prime Technologies provides prime brokerage solutions for clients to enter the digital asset space with a fully customizable suite of services. The company is based in Jersey City, NJ. Digital Prime Technologies is built on traditional finance principles and industry practices that are core to US regulated securities markets. The company's product suite allows traditional Wall Street firms and other clients to customize their prime offering for digital assets, including custody providers, risk management, margin requirements, and liquidity partners. The company's offering enables broker-dealers and capital markets firms to transact in the digital asset space with robust and fully customizable services suited to their business and compliance needs. The company was founded in 2019 by James A Runnels, who has been the CEO since 2019. | Technology Services |
